Вы искали: chelatbehandling (Датский - Английский)

lægen bør beslutte, hvilken behandling der bør anvendes, chelatbehandling eller zink.
which treatment should be used, zinc or chelating agent should be decided by the physician.

niveauet af kobber i urinen øges sædvanligvis i en chelatbehandling som penicillamin eller trientine.
urinary copper levels are usually increased with chelation therapy such as penicillamine or trientine.

som det er kendt for chelatbehandling kan der det i sjældne tilfælde forekomme en klinisk forværring.
although rare, clinical deterioration may occur at the beginning of the treatment, as has also been reported with chelating agents.

kroppens urinudskillelsen af kobber er kun en nøjagtig afspejling af kroppens niveaus, hvis patienten ikke er i en chelatbehandling.
the urinary excretion of copper is an accurate reflection of body loading with excess copper only when patients are not on chelation therapy.

hvis plasma zink niveauerne er markant forhøjede (>10 mg/l), så bør en tungmetal chelatbehandling overvejes.
heavy metal chelation therapy should be considered if plasma zinc levels are markedly elevated (> 10 mg/l).

når en patient skifter fra en chelatbehandling til wilzin vedligeholdelsesbehandling, skal chelatbehandlingen forsættes som samtidig behandling i 2- 3 uger, idet det er den tid det tager for at
when switching a patient on chelating treatment to wilzin for maintenance therapy, the chelating treatment should be maintained and co-administered for 2 to 3 weeks since this is the time it takes for 2 the zinc treatment to induce maximum metallothionein induction and full blockade of copper absorption.

når en patient skifter fra en chelatbehandling til wilzin vedligeholdelsesbehandling, skal chelatbehandlingen forsættes som samtidig behandling i 2-3 uger, idet det er den tid det tager for at zinkbehandlingen at inducere en maksimal metallothionein induktion og en fuldstændig blokering af kobber absorptionen.
when switching a patient on chelating treatment to wilzin for maintenance therapy, the chelating treatment should be maintained and co-administered for 2 to 3 weeks since this is the time it takes for the zinc treatment to induce maximum metallothionein induction and full blockade of copper absorption.

der skal gå mindst 1 time imellem indtagelse af chelatbehandlingen og wilzin.
the administration of the chelating treatment and wilzin should be separated by at least 1 hour.